Filters
BRAND
PRODUCT TYPE
(1801-2400 Activity Units (with BAXJECT II Device)- 5 mL) SKU 1503133
Important Notice
Takeda has decided to globally discontinue RECOMBINATE® effective at the end of September 2026, except for the 250 IU and 2000 IU presentations, which we currently anticipate will remain available through March 2027.
1801-2400 Activity Units; Including one vial dried Antihemophilic Factor (Recombinant); 5 mL Sterile Water for Injection, USP; one BAXJECT II Needleless Transfer Device; one physician insert; one patient insert.
(220-400 Activity Units (with BAXJECT II Device)- 5 mL) SKU 1502735
Important Notice
Takeda has decided to globally discontinue RECOMBINATE® effective at the end of September 2026, except for the 250 IU and 2000 IU presentations, which we currently anticipate will remain available through March 2027.
220-400 Activity Units; Including one vial dried Antihemophilic Factor (Recombinant); 5 mL Sterile Water for Injection, USP; one BAXJECT II Needleless Transfer Device; one physician insert; one patient insert.